why choose us

First received: December 12, 2022

Clinical Trial: A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Multiple Sclerosis

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Postmarketing Study of Dimethyl Fumarate (Tecfidera; BG00012) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China

Brief Summary: The primary objective of the study is to assess the efficacy of DMF in Chinese participants with RMS at Week 48.The secondary objectives of the study are to assess the efficacy and safety of DMF in Chinese participants with RMS.

Read more